Stocks · Health care · Pharmaceutical Preparations

GENELUX Corp

GNLX Clue Score27
United States Fiscal year ends December CIK 0001231457 Results filed 25 Mar 2025

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
John Thomas
1 Jun 2026
Director
Sold on a plan
10,000
$2.98
$29.80K
John Thomas
2 Mar 2026
Director
Sold on a plan
10,000
$2.90
$28.96K
John Thomas
1 Dec 2025
Director
Sold on a plan
10,000
$5.00
$50.01K

What was left out

Form 4 filings counted 36
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 25
Transactions with no price 0
Shares from compensation/vesting 1,651,259
History held since 30 Jan 2023